BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/10/2025 6:51:38 AM | Browse: 17 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 102224
Country China
Category Oncology
Manuscript Type Letter to the Editor
Article Title New frontiers in hepatocellular carcinoma: Precision imaging for microvascular invasion prediction
Manuscript Source Invited Manuscript
All Author List Liang Hao, Zhao-Nan Zhang, Shuang Han, Shan-Shan Li, Si-Xiang Lin and Yan-Dong Miao
Funding Agency and Grant Number
Funding Agency Grant Number
Shandong Province Medical and Health Science and Technology Development Plan Project 202203030713
Science and Technology Program of Yantai Affiliated Hospital of Binzhou Medical University YTFY2022KYQD06
Corresponding Author Yan-Dong Miao, Cancer Center, Yantai Affiliated Hospital of Binzhou Medical University,The 2nd Medical College of Binzhou Medical University, No. 717 Jinbu Street, Muping District, Yantai 264100, Shandong Province, China. miaoyd_22@bzmc.edu.cn
Key Words Microvascular invasion prediction; Hepatocellular carcinoma; Radiomics; Precision Imaging; Hepatitis B virus
Core Tip The integration of precision medicine in hepatocellular carcinoma (HCC) management is crucial for tailoring treatment to individual patient characteristics, and leveraging radiomics serves as a powerful non-invasive tool for predicting microvascular invasion preoperatively, thereby guiding more informed surgical decisions. To enhance the robustness and applicability of predictive models, multicentric studies involving diverse populations should be promoted, alongside the integration of radiomics with genetic and molecular markers for a more comprehensive understanding of the tumor microenvironment. Embracing advancements in imaging technologies and conducting cost-effectiveness analyses are essential for justifying the adoption of radiomics in clinical practice. Additionally, addressing ethical considerations regarding patient data privacy and promoting the use of radiomics in prospective clinical trials can help validate their effectiveness in real-world settings. Investing in training for healthcare professionals will improve their interpretation of radiomics data, facilitating its routine use, while fostering collaboration among oncologists, radiologists, data scientists, and researchers will continually refine predictive models and enhance their utility in managing HCC.
Citation Hao L, Zhang ZN, Han S, Li SS, Lin SX, Miao YD. New frontiers in hepatocellular carcinoma: Precision imaging for microvascular invasion prediction. World J Gastroenterol 2025; In press
Received
2024-10-12 07:05
Peer-Review Started
2024-10-12 07:05
To Make the First Decision
Return for Revision
2024-12-24 01:13
Revised
2025-01-02 05:57
Second Decision
2025-01-10 02:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-01-10 06:51
Articles in Press
2025-01-10 06:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
2025-01-11 10:53
Typeset the Manuscript
2025-01-16 09:49
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com